The FDA approved a molecular diagnostic test that can match blood donors using patient DNA.
In the wake of Hurricane Michael, the two largest dialysis companies in the country have opened their doors to all patients seeking treatment.
Deep Lens will offer a digital pathology tool developed at Nationwide Children's Hospital to pathologists all over the world—for free.
Medtronic disabled internet updates to two CareLink devices that program pacemakers amid concerns of cyberattack vulnerability, according to Reuters.
Otsuka and Proteus re-upped their smart-tablet partnership for another five years, aiming to develop a new generation of ingestible sensors.
Cardialen raised $17 million to fund its low-energy defibrillator that aims to avoid the negative effects of high-energy shocks.
Myriad Genetics and Pfizer have expanded and cemented their companion diagnostic agreement for the BRACAnalysis CDx test and talazoparib.
Oxford Nanopore launched MinIT, a pocket-size data analysis device that works with its portable MinION sequencer to offer mobile genomics research.
Digital health data from smart-inhaler maker Propeller Health found that certain clinical guidelines for assessing control of asthma may be outdated.
The FDA broadened its premarket approval of Carl Zeiss Meditec’s laser eye treatment to include nearsighted patients with astigmatism.